ENDRA Life Sciences
NDRA
5 hedge funds and large institutions have $70.4K invested in ENDRA Life Sciences in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
324% more capital invested
Capital invested by funds: $16.6K → $70.4K (+$53.8K)
67% more funds holding
Funds holding: 3 → 5 (+2)
1.1% more ownership
Funds ownership: 0.64% → 1.74% (+1.1%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$66.4K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$24K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DS
1
DRW Securities
Chicago,
Illinois
| $68.4K | +$66.4K | +12,714 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $1.21K | +$1.18K | +225 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $570 | -$24K | -4,589 | -98% |
|
4
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| $188 | – | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| $32 | – | – | – |
|
NDRA Hedge Fund Activity: Q3 2025 in Review
5 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2025, worth a combined $70.4K — up 324% from $16.6K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NDRA positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $66.4K. The largest seller was UBS Group, cutting an estimated $24K.
- 5 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2025, up from 3 in Q2 2025.
- Funds reported $70.4K of ENDRA Life Sciences stock for Q3 2025, up 324% quarter-over-quarter.
- 2 funds opened new ENDRA Life Sciences positions in Q3 2025 and 0 closed out, a net change of +2 holders.
- The largest ENDRA Life Sciences buyer in Q3 2025 was DRW Securities, an estimated $66.4K added.
- The largest ENDRA Life Sciences seller in Q3 2025 was UBS Group, an estimated $24K sold.
Based on aggregated 13F filings for Q3 2025.